Old Web
English
Sign In
Acemap
>
Paper
>
Bamlanivimab For Mild to Moderate COVID-19 in Kidney Transplant Recipients.
Bamlanivimab For Mild to Moderate COVID-19 in Kidney Transplant Recipients.
2021
Muhammad Y Jan
Skye E Sayegh
Hanna T. Webb
Oluwafisayo Adebiyi
Melissa Anderson
Dennis P. Mishler
Muhammad S. Yaqub
Tim E. Taber
Asif Sharfuddin
Keywords:
severe acute respiratory syndrome coronavirus 2
MEDLINE
Coronavirus disease 2019
kidney transplant
Medicine
Internal medicine
2019 20 coronavirus outbreak
Correction
Source
Cite
Save
Machine Reading By IdeaReader
8
References
2
Citations
NaN
KQI
[]